Pre-eclampsia, severe pre-eclampsia and hemolysis, elevated liver enzymes and low platelets syndrome: what is new? (Q37924287)

25 August 2017

1 reference

title

Pre-eclampsia, severe pre-eclampsia and hemolysis, elevated liver enzymes and low platelets syndrome: what is new? (English)

1 reference

25 August 2017

0 references

1 reference

James J Walker

2

0 references

author name string

Etienne Ciantar

series ordinal

1

1 reference

25 August 2017

1 September 2011

1 reference

25 August 2017

1 reference

25 August 2017

7

1 reference

25 August 2017

5

1 reference

25 August 2017

555-569

1 reference

25 August 2017

1 reference

The classification and definition of the hypertensive disorders of pregnancy

21 January 2018

1 reference

21 January 2018

1 reference

Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study

21 January 2018

1 reference

To ensure maternal mortality is reduced, quality of care needs to be monitored and improved alongside increasing skilled delivery coverage rates

21 January 2018

1 reference

Hypertensive disorders and severe obstetric morbidity in the United States

21 January 2018

1 reference

Clinical and geographical variation in prophylactic and therapeutic treatments for pre-eclampsia in the UK.

21 January 2018

1 reference

Immunology of placentation in eutherian mammals

21 January 2018

1 reference

Immunolocalization of tumour necrosis factor-alpha (TNF-alpha) in the placental bed of normotensive and hypertensive human pregnancies.

21 January 2018

1 reference

How Does the maternal immune system contribute to the development of pre-eclampsia?

21 January 2018

1 reference

Pre-eclampsia and changed paternity

21 January 2018

1 reference

Influence of previous blood-transfusion on incidence of pre-eclampsia

21 January 2018

1 reference

Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy

21 January 2018

1 reference

Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis.

21 January 2018

1 reference

Placental debris, oxidative stress and pre-eclampsia

21 January 2018

1 reference

Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer

21 January 2018

1 reference

Circulating angiogenic factors and the risk of preeclampsia

21 January 2018

1 reference

Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model

21 January 2018

1 reference

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

21 January 2018

1 reference

Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review.

21 January 2018

1 reference

Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1.

21 January 2018

1 reference

New insights into the etiology of preeclampsia: identification of key elusive factors for the vascular complications

21 January 2018

1 reference

Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women

21 January 2018

1 reference

Proteinuria in pre-eclampsia: how much matters?

21 January 2018

1 reference

The significance of proteinuria in pre-eclampsia; proteinuria associated with low birth weight only in pre-eclampsia

21 January 2018

1 reference

Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia

21 January 2018

1 reference

Perinatal outcomes in preeclampsia that is complicated by massive proteinuria

21 January 2018

1 reference

Estimation of proteinuria as a predictor of complications of pre-eclampsia: a systematic review

21 January 2018

1 reference

Accuracy of serum uric acid in predicting complications of pre-eclampsia: a systematic review.

21 January 2018

1 reference

Current CHS and NHBPEP criteria for severe preeclampsia do not uniformly predict adverse maternal or perinatal outcomes

21 January 2018

1 reference

Outcomes of severe pre-eclampsia/eclampsia in Yorkshire 1999/2003.

21 January 2018

1 reference

A critical appraisal of the use of umbilical artery Doppler ultrasound in high-risk pregnancies: use of meta-analyses in evidence-based obstetrics

21 January 2018

1 reference

How useful is uterine artery Doppler flow velocimetry in the prediction of pre-eclampsia, intrauterine growth retardation and perinatal death? An overview

21 January 2018

1 reference

Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial.

21 January 2018

1 reference

Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial

21 January 2018

1 reference

The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for women at 2 years

21 January 2018

1 reference

The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months

21 January 2018

1 reference

Cost-effectiveness of prophylactic magnesium sulphate for 9996 women with pre-eclampsia from 33 countries: economic evaluation of the Magpie Trial.

21 January 2018

1 reference

Posterior reversible encephalopathy syndrome in a patient with severe preeclampsia.

21 January 2018

1 reference

The HELLP syndrome: clinical issues and management. A Review

21 January 2018

1 reference

Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome)

21 January 2018

1 reference

Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count

21 January 2018

1 reference

The natural history of HELLP syndrome: patterns of disease progression and regression

21 January 2018

1 reference

The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification

21 January 2018

1 reference

Neonatal outcome in severe preeclampsia at 24 to 36 weeks' gestation: does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter?

21 January 2018

1 reference

Inflammation and preeclampsia.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/WHE.11.57

1 reference

25 August 2017

1 reference

PubMed ID

21879824